Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals Ownership Summary

Terns Pharmaceuticals is owned by 95.42% institutional investors, 0.29% insiders, and 4.29% retail investors. Soleus capital management is the largest institutional shareholder, holding 8.87% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.43% of its assets in Terns Pharmaceuticals shares.

TERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Terns Pharmaceuticals	95.42%	0.29%	4.29%
Sector	Healthcare Stocks	42.64%	10.86%	46.50%
Industry	Biotech Stocks	45.45%	10.77%	43.78%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Soleus capital management	8.13M	8.87%	$61.03M
Morgan stanley	7.59M	8.29%	$56.99M
Orbimed advisors	7.56M	8.26%	$56.80M
Deep track capital, lp	7.50M	8.18%	$56.29M
Vivo capital	6.90M	7.53%	$51.79M
Commodore capital lp	5.70M	6.22%	$42.81M
Blackrock funding, inc. /de	5.55M	6.06%	$41.69M
Vanguard group	5.52M	6.02%	$223.17M
Blackrock	4.12M	5.53%	$28.06M
Adage capital partners gp	3.94M	4.30%	$29.58M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acorn capital advisors	1.97M	7.52%	$14.80M
Superstring capital management lp	789.65K	5.84%	$5.93M
Vivo capital	6.90M	4.17%	$51.79M
Acuta capital partners	502.80K	3.90%	$3.78M
Soleus capital management	8.13M	3.07%	$61.03M
Eagle health investments lp	275.09K	2.44%	$11.11M
Commodore capital lp	5.70M	2.09%	$42.81M
Deep track capital, lp	7.50M	1.57%	$56.29M
Capricorn fund managers	151.44K	1.47%	$6.12M
Timessquare capital management	621.64K	1.45%	$92.18M

Top Buyers

Holder	Shares	% Assets	Change
Commodore capital lp	5.70M	2.09%	5.70M
Adage capital partners gp	3.94M	0.05%	2.66M
Vanguard group	5.52M	0.00%	964.03K
Norges bank	849.39K	0.00%	849.39K
Blackrock	4.12M	0.00%	804.98K

Top Sellers

Holder	Shares	% Assets	Change
Avidity partners management lp	-	-	-2.13M
Janus henderson group	-	-	-2.00M
Octagon capital advisors lp	-	-	-1.36M
Suvretta capital management	-	-	-1.36M
Schonfeld strategic advisors	1.89M	0.08%	-1.16M

New Positions

Holder	Shares	% Assets	Change	Value
Commodore capital lp	5.70M	2.09%	5.70M	$42.81M
Norges bank	849.39K	0.00%	849.39K	$4.71M
Eagle health investments lp	275.09K	2.44%	275.09K	$11.11M
Capricorn fund managers	151.44K	1.47%	151.44K	$6.12M
Platinum investment management	125.16K	0.06%	125.16K	$939.92K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
True wealth design	-11.00
Capital performance advisors llp	-23.00
Versant capital management	-36.00
Lindbrook capital	-63.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	139	6.92%	87,383,371	5.14%	95	1.16%	67	-6.94%	40	33.33%
Jun 30, 2025	129	-7.19%	83,090,778	-0.02%	90	1.10%	71	1.43%	30	-23.08%
Mar 31, 2025	139	-13.66%	83,111,324	-3.50%	90	0.74%	70	-33.33%	39	21.88%
Dec 31, 2024	149	-9.70%	81,944,156	3.09%	105	1.01%	94	-8.74%	31	-18.42%
Sep 30, 2024	165	17.86%	79,491,270	19.38%	102	1.28%	103	8.42%	38	65.22%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.12M	2.43%	-47.20K
Vanguard US Total Market Shares ETF	2.09M	2.39%	792.70K
iShares Russell 2000 ETF	1.77M	2.02%	-
Belfius Equities Cure C Cap	1.29M	1.47%	-
Fidelity Select Biotechnology	1.09M	1.29%	1.09M
Candriam Eqs L Biotech C USD Cap	1.08M	1.24%	-
CREF Stock R1	1.08M	1.23%	-160.00K
T. Rowe Price New Horizons	1.04M	1.23%	-
US Small-Cap Growth II Equity Comp	1.04M	1.23%	529.45K
Fidelity Small Cap Growth	877.41K	1.04%	-1.09M

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 15, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$282.23K
Jan 15, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$2.27M
Jan 05, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$2.72M
Jan 02, 2026	Kuriakose Emil	Chief Medical Officer	Sell	$36.63K
Jan 02, 2026	Kuriakose Emil	Chief Medical Officer	Sell	$7.92K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	5
2025 Q4	-	2
2025 Q3	-	1
2025 Q2	6	1
2025 Q1	-	5

TERN Ownership FAQ

Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals shareholders are primarily institutional investors at 95.42%, followed by 0.29% insiders and 4.29% retail investors. The average institutional ownership in Terns Pharmaceuticals's industry, Biotech Stocks , is 45.45%, which Terns Pharmaceuticals exceeds.

Who owns the most shares of Terns Pharmaceuticals?

Terns Pharmaceuticals’s largest shareholders are Soleus capital management (8.13M shares, 8.87%), Morgan stanley (7.59M shares, 8.29%), and Orbimed advisors (7.56M shares, 8.26%). Together, they hold 25.42% of Terns Pharmaceuticals’s total shares outstanding.

Does Blackrock own Terns Pharmaceuticals?

Yes, BlackRock owns 5.53% of Terns Pharmaceuticals, totaling 4.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 28.06M$. In the last quarter, BlackRock increased its holdings by 804.98K shares, a 24.28% change.

Who is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.52% of its assets in 1.97M Terns Pharmaceuticals shares, valued at 14.8M$.

Who is the top mutual fund holder of Terns Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Terns Pharmaceuticals shares, with 2.43% of its total shares outstanding invested in 2.12M Terns Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools